Cargando…

Patients' Preferences for Participation in Treatment Decision-Making at the End of Life: Qualitative Interviews with Advanced Cancer Patients

PURPOSE: Patients are often encouraged to participate in treatment decision-making. Most studies on this subject focus on choosing between different curative treatment types. In the last phase of life treatment decisions differ as they often put more emphasis on weighing quantity against quality of...

Descripción completa

Detalles Bibliográficos
Autores principales: Brom, Linda, Pasman, H. Roeline W., Widdershoven, Guy A. M., van der Vorst, Maurice J. D. L., Reijneveld, Jaap C., Postma, Tjeerd J., Onwuteaka-Philipsen, Bregje D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070976/
https://www.ncbi.nlm.nih.gov/pubmed/24964036
http://dx.doi.org/10.1371/journal.pone.0100435
_version_ 1782322756934696960
author Brom, Linda
Pasman, H. Roeline W.
Widdershoven, Guy A. M.
van der Vorst, Maurice J. D. L.
Reijneveld, Jaap C.
Postma, Tjeerd J.
Onwuteaka-Philipsen, Bregje D.
author_facet Brom, Linda
Pasman, H. Roeline W.
Widdershoven, Guy A. M.
van der Vorst, Maurice J. D. L.
Reijneveld, Jaap C.
Postma, Tjeerd J.
Onwuteaka-Philipsen, Bregje D.
author_sort Brom, Linda
collection PubMed
description PURPOSE: Patients are often encouraged to participate in treatment decision-making. Most studies on this subject focus on choosing between different curative treatment types. In the last phase of life treatment decisions differ as they often put more emphasis on weighing quantity against quality of life, such as whether or not to start treatment aimed at life prolongation but with the possibility of side effects. This study aimed to obtain insight into cancer patients' preferences and the reasons for patients' preferred role in treatment decision-making at the end of life. METHODS: 28 advanced cancer patients were included at the start of their first line treatment. In-depth interviews were held prior to upcoming treatment decisions whether or not to start a life prolonging treatment. The Control Preference Scale was used to start discussing the extent and type of influence patients wanted to have concerning upcoming treatment decision-making. Interviews were audio taped and transcribed. RESULTS: All patients wanted their physician to participate in the treatment decision-making process. The extent to which patients themselves preferred to participate seemed to depend on how patients saw their own role or assessed their own capabilities for participating in treatment decision-making. Patients foresaw a shift in the preferred level of participation to a more active role depending in the later phase of illness when life prolongation would become more limited and quality of life would become more important. CONCLUSION: Patients vary in how much involvement they would like to have in upcoming treatment decision-making. Individual patients' preferences may change in the course of the illness, with a shift to more active participation in the later phases. Communication about patients' expectations, wishes and preferences for participation in upcoming treatment decisions is of great importance. An approach in which these topics are openly discussed would be beneficial.
format Online
Article
Text
id pubmed-4070976
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-40709762014-06-27 Patients' Preferences for Participation in Treatment Decision-Making at the End of Life: Qualitative Interviews with Advanced Cancer Patients Brom, Linda Pasman, H. Roeline W. Widdershoven, Guy A. M. van der Vorst, Maurice J. D. L. Reijneveld, Jaap C. Postma, Tjeerd J. Onwuteaka-Philipsen, Bregje D. PLoS One Research Article PURPOSE: Patients are often encouraged to participate in treatment decision-making. Most studies on this subject focus on choosing between different curative treatment types. In the last phase of life treatment decisions differ as they often put more emphasis on weighing quantity against quality of life, such as whether or not to start treatment aimed at life prolongation but with the possibility of side effects. This study aimed to obtain insight into cancer patients' preferences and the reasons for patients' preferred role in treatment decision-making at the end of life. METHODS: 28 advanced cancer patients were included at the start of their first line treatment. In-depth interviews were held prior to upcoming treatment decisions whether or not to start a life prolonging treatment. The Control Preference Scale was used to start discussing the extent and type of influence patients wanted to have concerning upcoming treatment decision-making. Interviews were audio taped and transcribed. RESULTS: All patients wanted their physician to participate in the treatment decision-making process. The extent to which patients themselves preferred to participate seemed to depend on how patients saw their own role or assessed their own capabilities for participating in treatment decision-making. Patients foresaw a shift in the preferred level of participation to a more active role depending in the later phase of illness when life prolongation would become more limited and quality of life would become more important. CONCLUSION: Patients vary in how much involvement they would like to have in upcoming treatment decision-making. Individual patients' preferences may change in the course of the illness, with a shift to more active participation in the later phases. Communication about patients' expectations, wishes and preferences for participation in upcoming treatment decisions is of great importance. An approach in which these topics are openly discussed would be beneficial. Public Library of Science 2014-06-25 /pmc/articles/PMC4070976/ /pubmed/24964036 http://dx.doi.org/10.1371/journal.pone.0100435 Text en © 2014 Brom et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Brom, Linda
Pasman, H. Roeline W.
Widdershoven, Guy A. M.
van der Vorst, Maurice J. D. L.
Reijneveld, Jaap C.
Postma, Tjeerd J.
Onwuteaka-Philipsen, Bregje D.
Patients' Preferences for Participation in Treatment Decision-Making at the End of Life: Qualitative Interviews with Advanced Cancer Patients
title Patients' Preferences for Participation in Treatment Decision-Making at the End of Life: Qualitative Interviews with Advanced Cancer Patients
title_full Patients' Preferences for Participation in Treatment Decision-Making at the End of Life: Qualitative Interviews with Advanced Cancer Patients
title_fullStr Patients' Preferences for Participation in Treatment Decision-Making at the End of Life: Qualitative Interviews with Advanced Cancer Patients
title_full_unstemmed Patients' Preferences for Participation in Treatment Decision-Making at the End of Life: Qualitative Interviews with Advanced Cancer Patients
title_short Patients' Preferences for Participation in Treatment Decision-Making at the End of Life: Qualitative Interviews with Advanced Cancer Patients
title_sort patients' preferences for participation in treatment decision-making at the end of life: qualitative interviews with advanced cancer patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070976/
https://www.ncbi.nlm.nih.gov/pubmed/24964036
http://dx.doi.org/10.1371/journal.pone.0100435
work_keys_str_mv AT bromlinda patientspreferencesforparticipationintreatmentdecisionmakingattheendoflifequalitativeinterviewswithadvancedcancerpatients
AT pasmanhroelinew patientspreferencesforparticipationintreatmentdecisionmakingattheendoflifequalitativeinterviewswithadvancedcancerpatients
AT widdershovenguyam patientspreferencesforparticipationintreatmentdecisionmakingattheendoflifequalitativeinterviewswithadvancedcancerpatients
AT vandervorstmauricejdl patientspreferencesforparticipationintreatmentdecisionmakingattheendoflifequalitativeinterviewswithadvancedcancerpatients
AT reijneveldjaapc patientspreferencesforparticipationintreatmentdecisionmakingattheendoflifequalitativeinterviewswithadvancedcancerpatients
AT postmatjeerdj patientspreferencesforparticipationintreatmentdecisionmakingattheendoflifequalitativeinterviewswithadvancedcancerpatients
AT onwuteakaphilipsenbregjed patientspreferencesforparticipationintreatmentdecisionmakingattheendoflifequalitativeinterviewswithadvancedcancerpatients